Symposium

Green Builder Media’s Virtual Sustainability Symposium Is Coming Up ... Reserve Your Spot!

Retrieved on: 
Wednesday, March 27, 2024
Physics, Climate change, RMI (energy organization), Growth, Steel, Symposium, ESG, Politics, Symposium (Plato), Hope, Death, Wind, Nature, Life, Carbon, Outline, Green Builder Media, Trane Technologies, Whirlpool Corporation, Progress, Hydrogen, Apathy, Economics, Renewable energy

The Symposium, which is free to all attendees, will be held virtually over two days from 12:00-3:00 pm ET each day.

Key Points: 
  • The Symposium, which is free to all attendees, will be held virtually over two days from 12:00-3:00 pm ET each day.
  • Green Builder Media's dynamic CEO, Sara Gutterman, unveils the hottest sustainability trends revolutionizing the landscape for building professionals, homeowners, and businesses.
  • (If you want to read more details about the symposium before registering, check out the webpage here. )
  • A heartfelt thank you to Trane Technologies and Whirlpool Corporation for their continued support of our annual Sustainability Symposium, as well as their comprehensive commitment to corporate sustainability.

Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, March 26, 2024
Diabetic foot, Financial statement, PIN, Ulcer, Symposium, Sale, KNE, Pivot, Credit, Leg, SAWC, US FDA, Patent, FDA, Government, Food

WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial results.

Key Points: 
  • WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial results.
  • On December 20, 2023, Kane Biotech announced that it received a non-binding offer for its interest in STEM Animal Health.
  • Gross profit for the fourth quarter of 2023 was $398,234, an increase of 24% compared to $320,653 for the fourth quarter ended December 31, 2022.
  • Loss for the fourth quarter of 2023 was ($1,611,894), an increase of 92% compared to ($838,150) for the quarter ended December 31, 2022.

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Retrieved on: 
Thursday, March 21, 2024
Burn, Tax, Debridement, Patient, EWMA, Bank statement, Eschar, Investment, SAWC, Therapy, Depreciation, European Commission, Phase, BCC, Research, Supplement, Wound, EMA, GMP, HERE, Safety, CMS, BLA, Eastern Time Zone, Food, Bromelain (pharmacology), WBP, Development, PMI, WHS, Adjustment, FDA, BMCI, Forecasting, Symposium, Incidence, BSV, Basal-cell carcinoma, Operating cost, European Wound Management Association, Table, Event, Medicare, Pharmaceutical industry

YAVNE, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.

Key Points: 
  • Revenue: Revenue for the fourth quarter 2023 was $5.3 million, compared to $11.6 million in the fourth quarter of 2022.
  • Research and development expenses in the fourth quarter 2023 were $1.8 million compared to $2.7 million in the fourth quarter of 2022.
  • Selling, general, and administrative expenses in the fourth quarter 2023 were $2.8 million, compared to $3.0 million in the fourth quarter of 2022.
  • Operating Results: Operating loss in the fourth quarter of 2023 was $3.9 million, compared to an operating profit of $2.1 million in the fourth quarter of 2022.

Elliptic Labs Presenting the AI Virtual Smart Sensor Platform™ at Intel’s 2024 Client Ecosystem Symposium

Retrieved on: 
Thursday, March 21, 2024
Telecommunications, Software, Hardware, Artificial Intelligence, Consumer Electronics, Technology, Semiconductor, Mobile, Wireless, Intel, Organization, PC, Labs, ISV, Original equipment manufacturer, Symposium, Intelligence, Sleep, Ellipse, Life, Personal computer, Privacy, Medical device

Elliptic Labs (OSE: ELABS ), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, will be participating in the 2024 Intel Client Ecosystem Symposium onsite in Taipei, Taiwan, from March 28 – 29, 2024.

Key Points: 
  • Elliptic Labs (OSE: ELABS ), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, will be participating in the 2024 Intel Client Ecosystem Symposium onsite in Taipei, Taiwan, from March 28 – 29, 2024.
  • Elliptic Labs’ AI Virtual Seamless Sensor also enhances contextual awareness, allowing multiple devices to effortlessly discover, locate, identify, and connect with each other.
  • Our involvement in this year’s Symposium underscores the value the PC industry places on the innovation provided by our AI Virtual Smart Sensor Platform.
  • To learn more about the Intel Client Ecosystem Symposium, please visit: https://symposium.intel.com/Symposium/Home
    AI Virtual Smart Sensor, AI Virtual Proximity Sensor, and AI Virtual Smart Sensor Platform are trademarks of Elliptic Labs.

The Bennett Family of Companies Proud to Announce Launch of 50th Anniversary Celebration at the Truckload Carriers Association Truckload2024 Conference

Retrieved on: 
Tuesday, March 26, 2024
Attention, Celebration, Symposium, History, Transport, Family, MATS, AMS, NASCAR Xfinity Series, Anniversary Celebration, Atlanta Motor Speedway

MCDONOUGH, Ga., March 26, 2024 /PRNewswire-PRWeb/ -- The Bennett Family of Companies proudly announces the launch of its 50th Anniversary Celebration at the Truckload Carriers Association Truckload2024 conference today, commemorating half a century of Faith, Family and Freight in the transportation and logistics industry from 1974-2024.

Key Points: 
  • The Bennett Family of Companies proudly announces the launch of its 50th Anniversary Celebration at the Truckload Carriers Association Truckload2024 conference today, commemorating half a century of Faith, Family and Freight in the transportation and logistics industry from 1974-2024.
  • MCDONOUGH, Ga., March 26, 2024 /PRNewswire-PRWeb/ -- The Bennett Family of Companies proudly announces the launch of its 50th Anniversary Celebration at the Truckload Carriers Association Truckload2024 conference today, commemorating half a century of Faith, Family and Freight in the transportation and logistics industry from 1974-2024.
  • The Bennett Family of Companies proudly announces the launch of its 50th Anniversary Celebration at the Truckload Carriers Association Truckload2024 conference today, commemorating half a century of Faith, Family and Freight in the transportation and logistics industry from 1974-2024.
  • The event showcased the remarkable journey of the Bennett Family of Companies over the past five decades and set the stage for a year-long celebration.

Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Retrieved on: 
Thursday, March 7, 2024
Therapy, EDT, Participation, Parkinson's disease, GI, Patient, Symposium, Dementia, Pharmaceutical industry

“Parkinson’s disease remains one of the most prevalent neurodegenerative diseases worldwide, affecting more than a million people in the U.S. alone.

Key Points: 
  • “Parkinson’s disease remains one of the most prevalent neurodegenerative diseases worldwide, affecting more than a million people in the U.S. alone.
  • The 201 Trial evaluating three doses of risvodetinib in untreated Parkinson’s patients is beginning to yield information about the experience of participants on risvodetinib,” said Dr. Werner.
  • Ten mild and one moderate adverse event that might be related to treatment have been reported across all study participants.
  • Depending on the date of enrollment of the last participant, top line results from the 201 Trial might be reported in the second-half of 2024.

Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024

Retrieved on: 
Tuesday, March 5, 2024
SAN, Doctor of Philosophy, Research, FDA, Data collection, Growth, Overalls, Sale, Genomics, NGS, DSM-IV codes, Standard of care, IRB, Bone marrow, GAAP, Medicare, First Step, Genome, Data analysis, Symposium, OGM, Met, Publication, Comment, SOC, DNA, Cancer, Workflow, Video game

Total revenue for the fourth quarter of 2023 was $10.7 million, an increase of 30% compared to the fourth quarter of 2022.

Key Points: 
  • Total revenue for the fourth quarter of 2023 was $10.7 million, an increase of 30% compared to the fourth quarter of 2022.
  • GAAP gross margin for the fourth quarter of 2023 was 23%, which was slightly higher than the 22% GAAP gross margin reported for the fourth quarter of 2022.
  • Fourth quarter 2023 GAAP operating expense was $27.4 million, compared to $39.3 million in the fourth quarter of 2022.
  • Fourth quarter 2023 non-GAAP operating expense was $27.3 million, compared to $30.6 million in the fourth quarter of 2022.

The 2024 Integrative Healthcare Symposium Delivers Education, Networking and Business to Healthcare Professionals

Retrieved on: 
Tuesday, February 20, 2024
Community, LMT, MD, FACN, CNS, Organization, Symposium, Symposium (Plato), Nightclub

PORTLAND, Maine, Feb. 20, 2024 /PRNewswire-PRWeb/ -- The Integrative Healthcare Symposium, the premier east coast event for holistic and integrative healthcare professionals, hosted more than 1,700 industry professionals February 15-17 at the Hilton Midtown in New York City.

Key Points: 
  • More than 1,700 integrative healthcare practitioners, brand representatives and other professionals traveled to New York City for the annual Symposium
    PORTLAND, Maine, Feb. 20, 2024 /PRNewswire-PRWeb/ -- The Integrative Healthcare Symposium , the premier east coast event for holistic and integrative healthcare professionals, hosted more than 1,700 industry professionals February 15-17 at the Hilton Midtown in New York City.
  • - Christina Henderson, Event Director, Integrative Healthcare Symposium.
  • "Last week we brought together an incredible community of practitioners and healthcare professionals," said Christina Henderson, Event Director, Integrative Healthcare Symposium.
  • The 2025 Integrative Healthcare Symposium will take place February 20-22 at the Hilton Midtown in New York City.

Kenneth R. Pelletier, PhD, MD Receives 2024 Visionary Award at the Integrative Healthcare Symposium

Retrieved on: 
Saturday, February 17, 2024
CAMPS, UCSF, ASH, MD, NIH, Professor, Public health, Family, Rancho, Clinical professor, Life, University, FACN, Merrell, CNS, Symposium, Stanford University, CHIP

NEW YORK, Feb. 17, 2024 /PRNewswire-PRWeb/ -- Kenneth R. Pelletier, PhD, MD was today named the 2024 Visionary Award recipient at the Integrative Healthcare Symposium, taking place at the Hilton Midtown in New York City.

Key Points: 
  • NEW YORK, Feb. 17, 2024 /PRNewswire-PRWeb/ -- Kenneth R. Pelletier, PhD, MD was today named the 2024 Visionary Award recipient at the Integrative Healthcare Symposium , taking place at the Hilton Midtown in New York City.
  • — Kenneth R. Pelletier, PhD, MD
    Presented each year at the annual Symposium, the Visionary Award recognizes an industry leader whose contributions have shaped integrative healthcare and paved the way for other practitioners and professionals.
  • Dr. Pelletier will also play an active role at the 2024 Integrative Healthcare Symposium, presenting his session "Change Your Genes – Change Your Life: Epigenetics of Longevity" directly following the award ceremony on Saturday, February 17.
  • The 2024 Integrative Healthcare Symposium is held February 15-17, 2024 in New York City.

The Integrative Healthcare Symposium Kicks off 2024 Event with Education, Exhibits and Networking

Retrieved on: 
Friday, February 16, 2024
Community, Menopause, Organization, Patient, Symposium, Hospital

NEW YORK, Feb. 16, 2024 /PRNewswire-PRWeb/ -- The Integrative Healthcare Symposium today welcomed hundreds of practitioners to Day Two of the three-day event, taking place February 15-17 at the Hilton Midtown in New York City. The 2024 Symposium marks the 19th edition of the annual event.

Key Points: 
  • The 2024 Symposium marks the 19th edition of the annual event.
  • "This is my first Symposium as Event Director, and it's so inspiring to see these practitioners come together and share their passion for healthcare, patients and the industry," said Christina Henderson, Event Director, Integrative Healthcare Symposium.
  • "We're off to a great start, and the energy is high among both attendees and exhibitors," said Christina Henderson, Event Director, Integrative Healthcare Symposium.
  • The 2024 Integrative Healthcare Symposium is held February 15-17, 2024 in New York City.